Authors/Disclosures
|
Viktor Szeder, MD, PhD
|
Dr. Szeder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Szeder has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Carroll, Kelly, Trotter, Franzen, McBride & Peabody LLP. Dr. Szeder has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Peabody and Buccini LLP. |
|
|
No disclosure on file |
|
Na Tosha N. Gatson, MD, PhD, FÂ鶹´«Ã½Ó³»
|
Dr. Gatson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GT Medical Technologies. Dr. Gatson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Menarini Silicon Biosystems. Dr. Gatson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NuvOx Pharmaceuticals. Dr. Gatson has received publishing royalties from a publication relating to health care. Dr. Gatson has a non-compensated relationship as a Board Member with Society for Equity in Neurosciences (SEQUINS) that is relevant to Â鶹´«Ã½Ó³» interests or activities. |
|
|
No disclosure on file |
|
Nathalie M. Goemans, MD
(University Hospitals Leuven)
|
Dr. Goemans has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Goemans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Goemans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Goemans has received publishing royalties from a publication relating to health care. |
|
Sankeerth Challagundla, MD
(Prisma Health Neurology)
|
Dr. Challagundla has nothing to disclose. |
|
Osama O. Zaidat, MD, FÂ鶹´«Ã½Ó³»
(Neuroscience and Stroke Medical Director St Vincent Mercy Hospital)
|
Dr. Zaidat has nothing to disclose. |
|
Louise R. Rodino-Klapac
(Sarepta Therapeutics)
|
Ms. Rodino-Klapac has received personal compensation for serving as an employee of Sarepta Therapeutics, Inc.. Ms. Rodino-Klapac has received stock or an ownership interest from Sarepta Therapeutics. Ms. Rodino-Klapac has received intellectual property interests from a discovery or technology relating to health care. |
|
Linda P. Lowes, PT PhD
|
The institution of Ms. Lowes has received research support from Sarepta Therapeutics. |
|
|
No disclosure on file |
|
Jose L. Aceves, MD
(Baylor College of Medicine)
|
No disclosure on file |
|
Lindsay N. Alfano, PT
(Nationwide Children'S Hospital)
|
Ms. Alfano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ATOM International, Ltd (Amicus Therapeutics, Catabasis, Genethon, Italfarmaco, NS Pharma, Pfizer, PTC Therapeutics). Ms. Alfano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta Therapeutics. The institution of Ms. Alfano has received research support from Novartis Gene Therapies. The institution of Ms. Alfano has received research support from Sarepta Therapeutics. The institution of Ms. Alfano has received research support from Audentes Therapeutics/Astellas Gene Therapies. Ms. Alfano has received intellectual property interests from a discovery or technology relating to health care. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |